STC2 and hepatocellular carcinoma: Although our study was based on the bioinformatic analysis, we claim that the ten immune-related genes (BIRC5, CDK4, DCK, HSPA4, HSP90AA1, PSMD2, IL1RN, PGF, SPP1, and STC2) are novel targets for antitumor immunity, which may enrich the field for treating HCC patients.